ICCR meeting outcome
This article was originally published in The Rose Sheet
Executive Summary
FDA announces the availability of a document detailing the outcome of the International Cooperation on Cosmetic Regulation meeting, held in Brussels in September, in a March 7 Federal Register 1notice. The announcement is in keeping with FDA's commitment to transparency, and the agency will accept comments on the document until July 2, 2008. Cosmetic labeling and nanotechnology were among the issues discussed at the meeting, which included regulators from the U.S., Canada, the EU and Japan (2"The Rose Sheet" Oct. 15, 2007, p. 4)...
You may also be interested in...
ICCR Addresses Cosmetic Labeling, Nanotechnology At First Meeting
The International Cooperation on Cosmetics Regulation invites the cosmetics industry to generate and submit data showing that U.S. consumers understand the meaning of "trivial names" on product labeling
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.